Books.org participates in affiliate programs including Bookshop.org and the Amazon Services LLC Associates Program. We may earn a commission from qualifying purchases made through links on this page, at no additional cost to you.
Overview
The last few years have witnessed the creation of new generations of sequence reading compounds, which have incredible potential for targeting specific DNA sequences. In Drug DNA Interaction Protocols, Second Edition, expert researchers explore these compounds, revealing how a deeper understanding of the structure of DNA, along with an improved ability to manipulate it, has led to much progress in recent years. Chapters describe a new arsenal of techniques for probing the interactions between drugs an DNA, including various biophysical techniques for quantifying these interactions and for describing them in molecular and atomic detail, and they comprehensively consider both molecular and cellular approaches. Composed in the highly successful Methods in Molecular Biology? series format, each chapter contains a brief introduction, step-by-step methods, a list of necessary materials, and a Notes section which shares tips on troubleshooting and avoiding known pitfalls.
Authoritative and current-Drug DNA Interaction Protocols, Second Edition, is a critical volume that includes a wide range of chapters, which together provide methods for assessing the strength and mode of binding, the sequence selectivity, and the effect on biological systems.
The book contains black-and-white illustrations.
Synopsis
The last few years have witnessed the creation of new generations of sequence reading compounds, which have incredible potential for targeting specific DNA sequences. In "Drug-DNA Interaction Protocols, Second Edition", expert researchers explore these compounds, revealing how a deeper understanding of the structure of DNA, along with an improved ability to manipulate it, has led to much progress in recent years. Chapters describe a new arsenal of techniques for probing the interactions between drugs and DNA, including various biophysical techniques for quantifying these interactions and for describing them in molecular and atomic detail, and they comprehensively consider both molecular and cellular approaches. Composed in the highly successful Methods in Molecular Biology™ series format, each chapter contains a brief introduction, step-by-step methods, a list of necessary materials, and a Notes section which shares tips on troubleshooting and avoiding known pitfalls.
Authoritative and current, "Drug-DNA Interaction Protocols, Second Edition", is a critical volume that includes a wide range of chapters, which together provide methods for assessing the strength and mode of binding, the sequence selectivity, and the effect on biological systems.
Thomas M. Guenthner
This book describes numerous protocols and techniques for the analysis and quantization of drug-DNA interactions. It is intended to serve as a reference for scientists interested in measuring the degree to which drugs interact with chromosomal DNA. Numerous analytical techniques are described, and the book should be of value to researchers in this field. The book has 18 chapters, compiled by 33 international experts. The techniques are current and well described. The references are up-to-date, and the illustrations are helpful and of excellent quality. To members of a rather limited audience, this book should provide a very valuable technical resource. It must be mentioned that most of the techniques deal with "weak" drug-DNA interactions such as intercalation, or ionic or hydrophobic interactions. The interaction of DNA with alkylating agents or other covalently binding compounds is treated in only one section. The editor's intent seems to be to provide an extensive treatment of methods for measuring drug-DNA intercalation, essentially omitting those methods dealing with interaction of alkylating agents. This approach does not necessarily detract from the book, rather, it sharpens its focus. However, this approach also limits the audience somewhat. The book will be very valuable to those investigating drug-DNA intercalations. It will not be valuable to those interested in covalent drug-DNA interactions.
Editorials
From The Critics
Reviewer: Omer Iqbal, MD, FACC, FESC(Loyola University Medical Center)Description: This book provides authoritative and current information on the binding of new generations of DNA sequence reading compounds including triplex forming oligonucleotides and minor groove binding ligands to specific DNA sequences as anti-gene agents. This is an update of the previous edition published 12 years ago.
Purpose: This book is expected to be useful for established workers who wish to broaden their experimental repertoire, as well as for those who are new to the field and need expert advice and guidance.
Audience: The intended audience includes postgraduates, postdoctoral workers, and established scientists working in the field of drug-DNA interactions. However, even clinical investigators such as oncologists may find this book quite useful. Chapters are written by leading experts.
Features: Conveniently divided into 19 chapters, the book covers a wide range of approaches, from the cellular to the structural. The first nine chapters deal with various biophysical techniques such as thermal melting studies, capillary electrophoresis, and circular and linear dichroism of drug-DNA interactions, and other important techniques for quantifying drug-DNA interactions described in molecular and atomic detail. Other chapters cover molecular and cellular approaches of assessing the strength and mode of binding, the sequence selectivity, and their effect on biological systems. The final chapter details a series of biochemical, biophysical and cellular assays used to evaluate the activity of new compounds and to assess their suitability for examination in xenograft models of human cancer.
Assessment: This well-illustrated book of chapters written by leading experts will be extremely useful for postgraduates, post-doctoral fellows, established scientists, and some clinicians interested in the field of drug-DNA interactions. Given the significant advances in this field since the publication of the first edition in 1998, this update will be welcomed by students and justifies replacement.
Thomas M. Guenthner
This book describes numerous protocols and techniques for the analysis and quantization of drug-DNA interactions. It is intended to serve as a reference for scientists interested in measuring the degree to which drugs interact with chromosomal DNA. Numerous analytical techniques are described, and the book should be of value to researchers in this field. The book has 18 chapters, compiled by 33 international experts. The techniques are current and well described. The references are up-to-date, and the illustrations are helpful and of excellent quality. To members of a rather limited audience, this book should provide a very valuable technical resource. It must be mentioned that most of the techniques deal with "weak" drug-DNA interactions such as intercalation, or ionic or hydrophobic interactions. The interaction of DNA with alkylating agents or other covalently binding compounds is treated in only one section. The editor's intent seems to be to provide an extensive treatment of methods for measuring drug-DNA intercalation, essentially omitting those methods dealing with interaction of alkylating agents. This approach does not necessarily detract from the book, rather, it sharpens its focus. However, this approach also limits the audience somewhat. The book will be very valuable to those investigating drug-DNA intercalations. It will not be valuable to those interested in covalent drug-DNA interactions.Booknews
Cookbook-style instructions describe techniques developed to explore the interaction of drugs and ligands with DNA. The methods involve sequence recognition properties, as well as the physical approaches for measuring both the strength of interaction and the mode of drug binding to DNA. Interactions are examined from a cellular perspective and for their usefulness in the design of new therapeutic agents. Annotation c. by Book News, Inc., Portland, Or.3 Stars from Doody